Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial

Inclusion Criteria

• •Patients eligible for inclusion in this trial must meet all of the following criteria:
• •1. Written informed consent obtained according to international guidelines and local laws
• •2. Male and female patients aged ≥ 18 to ≤ 50 years
• •3. Patients with ON
• •4. First symptoms of ON ≤ 10 days prior to the first administration of investigational product
• •5. High contrast visual acuity (HCVA) of ≤ 0.5 (decimal system)
• •6. Adequate OCT measurements available
• •Patients eligible for this trial must not meet any of the following criteria:
• •1. Patient without legal capacity who is unable to understand the nature, significance and consequences of the trial
• •2. Simultaneous participation in another interventional trial which could interfere with this trial and/or participation in a clinical trial within the last 3 months before enrolment in this trial
• +38 more criteria